Amgen Articles
Biovitrum and Amgen close product deal
22 December 2008
Merck & Co unveils new biosimilars unit
15 December 2008
74% of ITP patients achieve platelet response on Nplate
15 December 2008
Amgen signs US deal with DxS for TheraScreen
8 December 2008
Oxford Genome Sciences re-named Oxford BioTherapeutics
8 December 2008
Ph III motesanib trial suspended on deaths
1 December 2008
CHMP gives nod to four new drugs at meeting
1 December 2008
CHMP OKs Novartis
1 December 2008
Japan stock market week to Nov 24, 2008
1 December 2008
Lasting benefits of CEL-SCI's RA vaccine demonstrated
24 November 2008
KHK's pharma sales up 58% in 1st-half 2009
24 November 2008
Kyowa Kirin hopes to become a biotech major
10 November 2008
Takeda's recurring profit down 70%
10 November 2008
Stock Commentary - New York week to Oct 27, 2008
3 November 2008
Wyeth's 3rd-qtr profit flat; AD drug delayed
3 November 2008
Amgen's 3rd-qtr 2008 profit leaps to $1.16B
3 November 2008
Japan MHLW Study C'ttee views developments
13 October 2008
Ariad gets favorable court ruling on Amgen litigation
13 October 2008
Cochrane meta-analysis confirms ESA AE profile
13 October 2008
Court affirms four Amgen EPO patents
13 October 2008
AMT gains license to Amgen technology for PD candidate
29 September 2008
J&J's epoetin-alfa linked to deaths in stroke trial
22 September 2008
Stock Commentary - New York week to Sept 15, 2008
22 September 2008
Three Rivers gets expanded rights to Infergen
22 September 2008
Teva gets EU approval for G-CSF generic
22 September 2008
Biovitrum pays Amgen initial $130M for drugs
22 September 2008
US FDA calls for tougher warnings on TNF-alpha drugs on 240 cases of histoplasmosis
15 September 2008
Genmab's loss deepens in first half of 2008
8 September 2008
FDA approves Amgen
1 September 2008
Japan stock market week to August 25, 2008
1 September 2008
FDA forces label-change for Amgen anemia drugs
1 September 2008
Stock Commentary - New York week to Aug 4, 2008
11 August 2008
J&J licenses Amgen drug for up to $435M
11 August 2008
Stock Commentary - New York week to July 28, 2008
4 August 2008
Barr confirms Sensipar patent challenge
4 August 2008
Amgen earnings down but outlook still up
4 August 2008
Stock Commentary - New York week to July 21, 2008
28 July 2008
Expected US approval of Amgen
28 July 2008
Lab21 ramps up KRAS and EGFR testing capacity
28 July 2008
NICE rejects second-line use of TNF-alpha drugs
28 July 2008
Japan stock market week to July 14, 2008
21 July 2008
Denosumab increases BMD in ADT patients
21 July 2008
Amgen and Ortho Bio settle antitrust suit
21 July 2008
Stock Commentary - New York week to July 7, 2008
14 July 2008
EMEA recommends new warnings on epoetins
7 July 2008
DxS launches K-RAS test in Australia
7 July 2008
Amgen's Mimpara approved by EC
30 June 2008
CORRECTION: Enbrel recommendation
30 June 2008
Amgen/Wyeth receive OK from FDA for Enbrel
30 June 2008
Long-term use potential for romiplostim
23 June 2008
Denosumab's BMD gain greater than Fosamax
9 June 2008
Japan stock market week to May 26, 2008
2 June 2008
Amgen
26 May 2008
Daiichi Sankyo takes over U3 Pharma
26 May 2008
Tokyo stocks to May 12, 2008
19 May 2008
Stock Commentary - New York week to May 12, 2008
19 May 2008
Chugai's 1st-qtr profit falls 50% to $63.7M
12 May 2008
Amgen reports nearly flat 1st qtr
5 May 2008
US drugmaker gift ban urged by AAMC
5 May 2008
U3 Pharma achieves proof-of-concept on U3-1287
21 April 2008
Amgen's AMG 386 aids tumor growth reduction
21 April 2008
Roche to appeal US Mircera sales bar
21 April 2008
Richard Clark elected chairman of PhRMA board
14 April 2008
Strong Ph III data for Amgen's denosumab
14 April 2008
Japanese drug firms adapting for growth
14 April 2008
EPIX discontinues MDD drug on poor efficacy
31 March 2008
11 defendants settle US AWP litigation
24 March 2008
Boxed warnings for Amgen/Wyeth's Enbrel
24 March 2008
Up to $420M deal for Kyowa Hakko/ Amgen
24 March 2008
FDA expert panel recommends Amgen ITP drug
17 March 2008
Ortho modifies Procrit Rxing info
17 March 2008
ESAs get EU label restrictions
10 March 2008
Centocor's psoriasis drug accepted for FDA review
10 March 2008
Japan stock market week to Feb 25, 2008
3 March 2008
EMEA's CHMP gives nod to Ratiopharm's Ratiograstim
3 March 2008
Ustekinumab: "gold standard" for psoriasis by 2011
18 February 2008
Tokyo stocks to February 11, 2008
18 February 2008
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
